CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $403,975
- in 4 filings, $404K under 10b5-1 plans
Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-03 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +17,786 | 17,786 | ||
| 2026-03-10 | Krainer Adrian R. Director | Sale 10b5-1 | −33,243 | $39.74 | $1.3M | 283,302 |
| 2026-03-02 | Krainer Adrian R. Director | Sale 10b5-1 | −7,229 | $39.66 | $287K | 316,545 |
| 2025-11-24 | Krainer Adrian R. Director | Sale 10b5-1 | −40,472 | $29.72 | $1.2M | 323,774 |
| 2025-11-14 | Krainer Adrian R. Director | Sale 10b5-1 | −19,790 | $26.61 | $527K | 384,928 |
| 2025-11-14 | Krainer Adrian R. Director | Sale 10b5-1 | −20,682 | $27.34 | $565K | 364,246 |
| 2025-06-03 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +29,747 | 29,747 | ||
| 2024-06-05 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2023-06-13 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +19,441 | 19,441 | ||
| 2022-06-07 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +21,000 | 21,000 |
Page 1 of 1 · 10 trades